CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC - Phase 2 | VTRS Pipeline | CatalystAlert